You have 9 free searches left this month | for more free features.

Sorafenib

Showing 1 - 25 of 1,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Carcinoma, Hepatocellular Trial in Loma Linda (Proton Beam Radiotherapy, Sorafenib)

Terminated
  • Carcinoma, Hepatocellular
  • Proton Beam Radiotherapy
  • Sorafenib
  • Loma Linda, California
    Loma Linda University Medical Center
Sep 21, 2021

Hepatocellular Carcinoma, Hepatitis B, Hepatitis C Trial in Duarte, Singapore (MTL-CEBPA, Sorafenib)

Recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • Duarte, California
  • +1 more
Feb 20, 2022

HepatoCellular Carcinoma, Portal Vein Thrombosis Trial in Beijing (HAIC, Sorafenib)

Completed
  • HepatoCellular Carcinoma
  • Portal Vein Thrombosis
  • HAIC
  • Sorafenib
  • Beijing, Beijing, China
    Peking University Cancer Hospital
Oct 8, 2021

Differentiated Thyroid Cancer Trial in Philadelphia (Everolimus, Sorafenib)

Active, not recruiting
  • Differentiated Thyroid Cancer
  • Philadelphia, Pennsylvania
    Hospital of the University of Pennsylvania
Oct 18, 2021

Advanced Hepatocellular Carcinoma Trial (Sorafenib)

Not yet recruiting
  • Advanced Hepatocellular Carcinoma
  • Sorafenib
  • (no location specified)
Nov 2, 2021

Hepatocellular Carcinoma Trial in Dhaka (Lenvatinib)

Recruiting
  • Hepatocellular Carcinoma
  • Dhaka, Bangladesh
  • +1 more
May 21, 2022

Prostate Cancer Trial in Philadelphia (docetaxel, sorafenib tosylate)

Completed
  • Prostate Cancer
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Feb 16, 2022

Hepatocellular Carcinoma, Radiotherapy, Sorafenib Trial in Beijing (concurrent sorafenib and IMRT, followed sorafenib

Completed
  • Hepatocellular Carcinoma, Radiotherapy, Sorafenib
  • concurrent sorafenib and IMRT, followed sorafenib maintenance
  • Beijing, Beijing, China
    Bo Chen
Jun 16, 2021

Prospective, Non-interventional, Post-authorization Safety Study

Active, not recruiting
  • Thyroid Carcinoma
  • Sorafenib (Nexavar, BAY43-9006)
  • Multiple Locations, Japan
    (unnamed)
Aug 18, 2022

Refractory Solid Tumor, Hepatocellular Carcinoma, Malignant Solid Tumor Trial in Memphis (Atezolizumab, Sorafenib, Bevacizumab)

Recruiting
  • Refractory Solid Tumor
  • +4 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Aug 4, 2022

Advanced Solid Tumors, Hepatocellular Carcinoma Trial in Chiba, Etc. (BBI503, Sorafenib)

Completed
  • Advanced Solid Tumors
  • Hepatocellular Carcinoma
  • Chiba, Etc., Japan
    5 Sites
Apr 9, 2022

Hepatocellular Carcinoma, Hepatoma Trial in Baltimore (sorafenib, LC Bead-TACE)

Completed
  • Hepatocellular Carcinoma
  • Hepatoma
  • sorafenib
  • LC Bead-TACE
  • Baltimore, Maryland
    The Johns Hopkins Hospital
Oct 15, 2021

Hepatocellular Carcinoma Trial in Toronto (Sorafenib)

Completed
  • Hepatocellular Carcinoma
  • Sorafenib
  • Toronto, Ontario, Canada
    University Health Network
Oct 4, 2021

The Gut Microbiome in FLT3- AL Undergoing Allo-HSCT With Or

Recruiting
  • Acute Leukemia
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • Sorafenib
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Oct 28, 2022

Advanced Adult Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, Recurrent Adult Hepatocellular Carcinoma Trial

Completed
  • Advanced Adult Hepatocellular Carcinoma
  • +10 more
  • Laboratory Biomarker Analysis
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 1, 2021

Hepatocellular Carcinoma Trial in Guangzhou (HAIC, Sorafenib)

Completed
  • Hepatocellular Carcinoma
  • HAIC
  • Sorafenib
  • Guangzhou, Guangdong, China
    Cancer Center Sun Yat-sen University
Nov 16, 2021

Hepatocellular Carcinoma, Advanced Cancer Trial in Charleston, Tainan, Taipei (Sorafenib, CVM-1118)

Active, not recruiting
  • Hepatocellular Carcinoma
  • Advanced Cancer
  • Charleston, South Carolina
  • +2 more
Jan 25, 2022

The Gut Microbiome in FLT3-ITD+ AML Undergoing Allo-HSCT With Or

Recruiting
  • Acute Myeloid Leukemia With FLT3/ITD Mutation
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • Sorafenib
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Oct 25, 2022

Pancreas Cancer Trial in Scottsdale (Vemurafenib, Sorafenib)

Recruiting
  • Pancreas Cancer
  • Scottsdale, Arizona
    HonorHealth Research Institute
Oct 28, 2021

The Gut Microbiome and Sorafenib Maintenance Therapy in FLT3-ITD

Recruiting
  • Acute Myeloid Leukemia With FLT3/ITD Mutation
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • Sorafenib
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Oct 25, 2022

Hepatocellular Cancer Trial in San Antonio (Sorafenib (SOR), Hydroxychloroquine (HCQ))

Recruiting
  • Hepatocellular Cancer
  • Sorafenib (SOR)
  • Hydroxychloroquine (HCQ)
  • San Antonio, Texas
    University of Texas Health Cancer Center
May 25, 2021

Breast Cancer, Brain Metastases Trial in United States (Whole Brain Radiotherapy (WBRT), Sorafenib)

Completed
  • Breast Cancer
  • Brain Metastases
  • Whole Brain Radiotherapy (WBRT)
  • Sorafenib
  • Basking Ridge, New Jersey
  • +5 more
Mar 4, 2022

Hepatocellular Carcinoma Trial in Shanghai (IBI310, Sintilimab, Sorafenib)

Recruiting
  • Hepatocellular Carcinoma
  • Shanghai, Shanghai, China
    Fudan Universtiy Zhongshan Hospital
Nov 26, 2021

Core Binding Factor Acute Myeloid Leukemia Trial in Guangzhou (Sorafenib, Idarubicin, Cytarabine)

Recruiting
  • Core Binding Factor Acute Myeloid Leukemia
  • Sorafenib
  • +2 more
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
May 31, 2022

Called ROCURS, to Learn About COVID-19 Related Outcomes in

Not yet recruiting
  • Malignant Solid Tumors
  • +2 more
  • Whippany, New Jersey
    Bayer
Oct 21, 2022